Clinical trials
Trachoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Withdrawn | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 13 |
| Johns Hopkins University | 7 |
| London School of Hygiene and Tropical Medicine | 7 |
| Emory University | 3 |
| Baskent University | 1 |
| Centre d'Appui à la lutte contre la Maladie | 1 |
| Laboratoires Thea | 1 |
| Lihir Medical Centre | 1 |
| Statens Serum Institut | 1 |
| University of North Carolina, Chapel Hill | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Trachoma | 38 |
| Chlamydia Infections | 6 |
| Trichiasis | 6 |
| Bacterial Infections | 4 |
| Elephantiasis, Filarial | 4 |
| Eye Diseases | 3 |
| Infections | 2 |
| Neglected Diseases | 2 |
| Amblyopia | 1 |
| Astigmatism | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.